Pfizer Invites Public to View & Listen to Webcast of May 15 Conference Call with Analysts to Review Duchenne Muscular Dystrop...
May 08 2020 - 10:00AM
Business Wire
Pfizer Inc. (NYSE: PFE) invites investors and the general public
to view and listen to a webcast of a conference call with
investment analysts on Friday, May 15, 2020 at 10:00 a.m. EDT. The
purpose of the call is to review the DMD data presentation at the
American Society of Gene and Cell Therapy (ASGCT) 2020 Annual
Meeting.
To view and listen to the webcast, visit our web site at
www.pfizer.com/investors. Information on accessing and
pre-registering for the webcast will be available at
www.pfizer.com/investors beginning today. Participants are advised
to pre-register in advance of the conference call.
You can also listen to the conference call by dialing either
(866) 669-8582 in the United States and Canada or (702) 495-1304
outside of the United States and Canada. The password is “ASGCT
2020”.
Visitors will be able to view and listen to an archived copy of
the webcast at www.pfizer.com/investors.
About Pfizer: Breakthroughs That Change Patients’
Lives
At Pfizer, we apply science and our global resources to bring
therapies to people that extend and significantly improve their
lives. We strive to set the standard for quality, safety and value
in the discovery, development and manufacture of health care
products, including innovative medicines and vaccines. Every day,
Pfizer colleagues work across developed and emerging markets to
advance wellness, prevention, treatments and cures that challenge
the most feared diseases of our time. Consistent with our
responsibility as one of the world's premier innovative
biopharmaceutical companies, we collaborate with health care
providers, governments and local communities to support and expand
access to reliable, affordable health care around the world. For
more than 150 years, we have worked to make a difference for all
who rely on us. We routinely post information that may be important
to investors on our website at www.Pfizer.com. In addition, to
learn more, please visit us on www.Pfizer.com and follow us on
Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us
on Facebook at Facebook.com/Pfizer.
Disclosure Notice: The webcast may include
forward-looking statements about, among other things, Pfizer’s
investigational DMD gene therapy program, PF-06939926, including
its potential benefits, that are subject to substantial risks and
uncertainties that could cause actual results to differ materially
from those expressed or implied by such statements. A description
of these risks and uncertainties can be found in Pfizer’s Annual
Report on Form 10-K for the fiscal year ended December 31, 2019 and
in its subsequent reports on Form 10-Q, including in the sections
thereof captioned “Risk Factors” and “Forward-Looking Information
and Factors That May Affect Future Results”, as well as in its
subsequent reports on Form 8-K, all of which are filed with the
U.S. Securities and Exchange Commission and available at
www.sec.gov and www.pfizer.com.
The forward-looking statements in the webcast speak only as of
the original date of the webcast. Pfizer assumes no obligation to
update forward-looking statements contained in the webcast as the
result of new information or future events or developments.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200508005024/en/
Media Relations:
Steven Danehy +1 (978) 273-3946 Steven.Danehy@Pfizer.com Investor Relations: Bryan Dunn +1 (212) 733-8917 Bryan.Dunn@Pfizer.com
Pfizer (NYSE:PFE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Apr 2023 to Apr 2024